Willis Little

Array ( [id] => 6658329 [patent_doc_number] => 20030133944 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-17 [patent_title] => 'Vaccine composition against malaria' [patent_app_type] => new [patent_app_number] => 10/299619 [patent_app_country] => US [patent_app_date] => 2002-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2702 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0133/20030133944.pdf [firstpage_image] =>[orig_patent_app_number] => 10299619 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6977895 [patent_doc_number] => 20050287613 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-29 [patent_title] => 'Polyclonal-polyclonal ELISA assay for detecting N-terminus-proBNP' [patent_app_type] => utility [patent_app_number] => 10/299977 [patent_app_country] => US [patent_app_date] => 2002-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5915 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0287/20050287613.pdf [firstpage_image] =>[orig_patent_app_number] => 10299977 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7471107 [patent_doc_number] => 20040096919 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-20 [patent_title] => 'Polyclonal-monoclonal ELISA assay for detecting N-terminus proBNP' [patent_app_type] => new [patent_app_number] => 10/300733 [patent_app_country] => US [patent_app_date] => 2002-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6387 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 134 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0096/20040096919.pdf [firstpage_image] =>[orig_patent_app_number] => 10300733 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6761275 [patent_doc_number] => 20030124637 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-03 [patent_title] => 'Process for analyzing annexin-V in urine, and application thereof' [patent_app_type] => new [patent_app_number] => 10/294558 [patent_app_country] => US [patent_app_date] => 2002-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 12130 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20030124637.pdf [firstpage_image] =>[orig_patent_app_number] => 10294558 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7202931 [patent_doc_number] => 20050042678 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-24 [patent_title] => 'Method of using physiological markers to estimate cardiovascular risk' [patent_app_type] => utility [patent_app_number] => 10/495081 [patent_app_country] => US [patent_app_date] => 2002-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5360 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0042/20050042678.pdf [firstpage_image] =>[orig_patent_app_number] => 10495081 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6851435 [patent_doc_number] => 20030143638 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-31 [patent_title] => 'Antibody/carrier complex, process for producing the same, method of controlling antigen-antibody reaction by using the same and immunoassay method' [patent_app_type] => new [patent_app_number] => 10/240862 [patent_app_country] => US [patent_app_date] => 2002-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 4844 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20030143638.pdf [firstpage_image] =>[orig_patent_app_number] => 10240862 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6778611 [patent_doc_number] => 20030049692 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-13 [patent_title] => 'Detection of anti-glycolipid antibodies by latex agglutination assay' [patent_app_type] => new [patent_app_number] => 10/088775 [patent_app_country] => US [patent_app_date] => 2002-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 9584 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0049/20030049692.pdf [firstpage_image] =>[orig_patent_app_number] => 10088775 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 675583 [patent_doc_number] => 07087396 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-08-08 [patent_title] => 'Monoclonal antibody and method and kit for immunoassay of soluble human ST2' [patent_app_type] => utility [patent_app_number] => 10/243949 [patent_app_country] => US [patent_app_date] => 2002-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 12142 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/087/07087396.pdf [firstpage_image] =>[orig_patent_app_number] => 10243949 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7308778 [patent_doc_number] => 20040142400 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-22 [patent_title] => 'High affinity monoclonal antibody for recognizing the estrogen receptor (ER) and method for creating the antibody' [patent_app_type] => new [patent_app_number] => 10/242088 [patent_app_country] => US [patent_app_date] => 2002-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5081 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20040142400.pdf [firstpage_image] =>[orig_patent_app_number] => 10242088 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 263910 [patent_doc_number] => 07569675 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-08-04 [patent_title] => 'High affinity monoclonal antibody for recognizing the progesterone receptor (PR) and method for creating the antibody' [patent_app_type] => utility [patent_app_number] => 10/242092 [patent_app_country] => US [patent_app_date] => 2002-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4905 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/569/07569675.pdf [firstpage_image] =>[orig_patent_app_number] => 10242092 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 676511 [patent_doc_number] => 07087727 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-08-08 [patent_title] => 'Periostin-based diagnostic assays' [patent_app_type] => utility [patent_app_number] => 10/217371 [patent_app_country] => US [patent_app_date] => 2002-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 14461 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/087/07087727.pdf [firstpage_image] =>[orig_patent_app_number] => 10217371 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7334864 [patent_doc_number] => 20040132117 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-08 [patent_title] => 'Immunoassay and diagnostic reagent for malaria' [patent_app_type] => new [patent_app_number] => 10/182700 [patent_app_country] => US [patent_app_date] => 2002-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 14694 [patent_no_of_claims] => 60 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0132/20040132117.pdf [firstpage_image] =>[orig_patent_app_number] => 10182700 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6750345 [patent_doc_number] => 20030044865 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-06 [patent_title] => 'ELISA for VEGF' [patent_app_type] => new [patent_app_number] => 10/211282 [patent_app_country] => US [patent_app_date] => 2002-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 15519 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0044/20030044865.pdf [firstpage_image] =>[orig_patent_app_number] => 10211282 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7275538 [patent_doc_number] => 20040234989 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-25 [patent_title] => 'Method for the diagnosis of kidney damage in the early stages' [patent_app_type] => new [patent_app_number] => 10/485039 [patent_app_country] => US [patent_app_date] => 2004-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 8930 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20040234989.pdf [firstpage_image] =>[orig_patent_app_number] => 10485039 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6817761 [patent_doc_number] => 20030068719 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-10 [patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same' [patent_app_type] => new [patent_app_number] => 10/198762 [patent_app_country] => US [patent_app_date] => 2002-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 616 [patent_figures_cnt] => 616 [patent_no_of_words] => 61087 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0068/20030068719.pdf [firstpage_image] =>[orig_patent_app_number] => 10198762 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7116646 [patent_doc_number] => 20050069947 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-31 [patent_title] => ' Antibodies specific for nanotubes and related methods and compositions' [patent_app_type] => utility [patent_app_number] => 10/484031 [patent_app_country] => US [patent_app_date] => 2002-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 34 [patent_no_of_words] => 25791 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20050069947.pdf [firstpage_image] =>[orig_patent_app_number] => 10484031 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6668956 [patent_doc_number] => 20030113940 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-19 [patent_title] => 'Antibodies specific for nanotubes and related methods and compositions' [patent_app_type] => new [patent_app_number] => 10/197080 [patent_app_country] => US [patent_app_date] => 2002-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 37 [patent_no_of_words] => 26317 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20030113940.pdf [firstpage_image] =>[orig_patent_app_number] => 10197080 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7326904 [patent_doc_number] => 20040253234 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-16 [patent_title] => 'Humanized antibody against fibroblast growth factor-8 and antibody fragment thereof' [patent_app_type] => new [patent_app_number] => 10/482105 [patent_app_country] => US [patent_app_date] => 2004-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 25597 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0253/20040253234.pdf [firstpage_image] =>[orig_patent_app_number] => 10482105 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6720728 [patent_doc_number] => 20030054416 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-20 [patent_title] => 'Test for oxidative stress using cell suspensions' [patent_app_type] => new [patent_app_number] => 10/179300 [patent_app_country] => US [patent_app_date] => 2002-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4820 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 274 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20030054416.pdf [firstpage_image] =>[orig_patent_app_number] => 10179300 [rel_patent_id] =>[rel_patent_doc_number] =>)